Blood Diseases Market Research Reports & Industry Analysis
Blood Diseases Industry Research & Market Reports
-
Global Sickle-cell Anemia Therapeutics Market Growth (Status and Outlook) 2023-2029
... the body. The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglobin known as sickle hemoglobin (HbS). LPI (LP Information)' newest research report, the ... Read More
-
Global Renal Anemia Therapeutics Market Growth (Status and Outlook) 2023-2029
... 2022, providing a comprehensive analysis by region and market sector of projected Renal Anemia Therapeutics sales for 2023 through 2029. With Renal Anemia Therapeutics sales broken down by region, market sector and sub-sector, this report ... Read More
-
Immune Thrombocytopenia (ITP) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... 1.6 million diagnosed prevalent cases of ITP in 2023 across 16 pharmaceutical markets. There are four leading marketed innovator drugs for the treatment of ITP, majority of marketed products are thrombopoietin receptor agonist. R&D activity ... Read More
-
Thalassemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Thalassemia Clinical trials scenario. This report provides top line data relating to the clinical trials on Thalassemia. Report includes ... Read More
-
Global Bleeding Disorders Treatment Market Size study & Forecast, by Type (Hemophilia A, Hemophilia B, Von Willebrand Disease, Others), by Drug Class (Plasma-derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antifibrinolytics, Fibrin Sealants, Others) and Regional Analysis, 2022-2029
... and Regional Analysis, 2022-2029 Global Bleeding Disorders Treatment Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast ... Read More
-
Aplastic Anemia Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies
... clinical stage pipeline candidates under development as of H1- 2023. For each of the Aplastic Anemia pipeline candidate, details of leading companies, phase of development, mechanism of action, route of administration, molecule type, and other ... Read More
-
Chemotherapy Induced Anemia Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies
... pre-clinical and clinical stage pipeline candidates under development as of H1- 2023. For each of the Chemotherapy Induced Anemia pipeline candidate, details of leading companies, phase of development, mechanism of action, route of administration, molecule ... Read More
-
Iron Deficiency Anemia Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies
... pre-clinical and clinical stage pipeline candidates under development as of H1- 2023. For each of the Iron Deficiency Anemia pipeline candidate, details of leading companies, phase of development, mechanism of action, route of administration, molecule ... Read More
-
Anemia in Chronic Kidney Disease (Renal Anemia) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies
... Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1- 2023. For each of the Anemia in Chronic Kidney Disease (Renal Anemia) pipeline candidate, details of ... Read More
-
Fanconi Anemia Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies
... clinical stage pipeline candidates under development as of H1- 2023. For each of the Fanconi Anemia pipeline candidate, details of leading companies, phase of development, mechanism of action, route of administration, molecule type, and other ... Read More
-
Global Hemophilia Drugs Market Growth 2023-2029
... factors and more promising drugs are on their way to get launched in this market. For instance, follow up data from phase I/II study of hemophilia medicine ‘Emicizumab’ by Roche has demonstrated promising results regarding ... Read More
-
Global Anemia and Vitamin Test Market Growth (Status and Outlook) 2023-2029
... important to functioning of the human being. Haemoglobin is a part of RBC that carries oxygen to the various body tissue. If a person has less number of RBC or low level of haemoglobin that ... Read More
-
Iron Deficiency Anemia Market Size Outlook in 2023 and Beyond: Market Trends, Insights, Growth Opportunities, Market Share and Forecasts by Types, Applications, Countries and Companies to 2030
... to register solid growth in the sector in 2023 and beyond. The Iron Deficiency Anemia market report analyzes the Iron Deficiency Anemia market growth opportunities, trends, insights, and market size outlook across types, applications, and ... Read More
-
Sickle Cell Anemia Testing & Screening Market Intelligence Report - Global Forecast 2023-2030
... in 2022, at a CAGR 13.49% during the forecast period. Market Statistics: The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support ... Read More
-
Global PEGylated Proteins Market Size study & Forecast, by Protein Type (Colony-stimulating factor, Interferons, Erythropoietin, Recombinant factor VII, Others), by Product & Services (Consumables, Services), by Application (Cancer, Autoimmune diseases, Hepatitis, Multiple sclerosis, Hemophilia, Gastrointestinal disorders, Others), by End-User (Pharmaceutical & biotechnology companies, Contract research organizations, Academic & research institutes), and Regional Analysis, 2022-2029
... disorders, Others), by End-User (Pharmaceutical & biotechnology companies, Contract research organizations, Academic & research institutes), and Regional Analysis, 2022-2029 Global PEGylated Proteins Market is valued at approximately USD 1.14 billion in 2021 and is anticipated ... Read More
-
Iron Deficiency Anemia Therapy Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
... - 2027). The COVID-19 pandemic had a significant impact on the healthcare systems, with significant consequences not only for COVID-19-infected patients but also for others, resulting in the cancellation of treatment and procedures to manage ... Read More
-
Global Rare Haematology Market - 2023-2030
... CAGR of XX% during the forecast period (2023-2030). A small number of individuals have rare blood diseases. They can impact platelets, red blood cells, or white blood cells, which makes it challenging to transfer oxygen ... Read More
-
Global Hemophilia Gene Therapy Market Growth (Status and Outlook) 2023-2029
... a genetic defect in a single gene). There are two types of hemophilia caused by mutations in genes that encode protein factors which help the blood clot and stop bleeding when blood vessels are injured. ... Read More
-
Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales Market Report 2022
... worth US$ 674.7 million in 2022 and is forecast to a readjusted size of US$ 1314.68 million by 2028 with a CAGR of 11.76% during the review period. Fully considering the economic change by this ... Read More
-
Bleeding Disorders Treatment Global Market Report 2022: Ukraine-Russia War Impact
... information they need to assess the global bleeding disorders treatment market. This report focuses on bleeding disorders treatment market which is experiencing strong growth. The report gives a guide to the bleeding disorders treatment market ... Read More
-
Anemia in Chronic Kidney Disease (Renal Anemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Chronic Kidney Disease (Renal Anemia) - Drugs In Development, 2022, provides an overview of the Anemia in Chronic Kidney Disease (Renal Anemia) (Hematological Disorders) pipeline landscape. Renal anemia is a disease in which the patient ... Read More
-
Europe Hemoglobinopathies Market Size, Share & Industry Trends Analysis Report By Type (Thalassemia, Sickle Cell Disease), By Distribution Channel, By Therapy (Monoclonal Antibody Medication, Hydroxyurea, ACE Inhibitors), By Country and Growth Forecast, 2022 - 2028
... The Europe Hemoglobinopathies Market would witness market growth of 5.2% CAGR during the forecast period (2022-2028). HbS, HbD, HbE, and HbG are more frequently seen as beta-globin variants. A mutation in one beta globin component ... Read More
-
Global Hemoglobinopathies Market Size, Share & Industry Trends Analysis Report By Type (Thalassemia, Sickle Cell Disease), By Distribution Channel, By Therapy (Monoclonal Antibody Medication, Hydroxyurea, ACE Inhibitors), By Regional Outlook and Forecast, 2022 - 2028
... The Global Hemoglobinopathies Market size is expected to reach $6.0 billion by 2028, rising at a market growth of 5.6% CAGR during the forecast period. In its stable state, normal human hemoglobin’s are tetrameric protein ... Read More
-
North America Hemoglobinopathies Market Size, Share & Industry Trends Analysis Report By Type (Thalassemia, Sickle Cell Disease), By Distribution Channel, By Therapy (Monoclonal Antibody Medication, Hydroxyurea, ACE Inhibitors), By Country and Growth Forecast, 2022 - 2028
... 2028 The North America Hemoglobinopathies Market would witness market growth of 5.1% CAGR during the forecast period (2022-2028). Tetramer hemoglobin consists of two alpha globin and two non-alpha globin chains, and Heme works together to ... Read More
-
Middle East & Africa Blood Transfusion Diagnostics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Instruments & Kits and Reagents), Application (Blood Grouping and Disease Screening), and End User (Hospitals, Diagnostic Laboratories, Blood Banks, and Plasma Fractionation Companies)
... Diagnostic Laboratories, Blood Banks, and Plasma Fractionation Companies) The MEA blood transfusion diagnostics market is expected to grow from US$ 151.99 million in 2022 to US$ 199.02 million by 2028. It is estimated to grow ... Read More
Research Assistance
